World Health Organization : Year 1995 : Communicable Diseases and Emerging Infectious Diseases ; Vph, No. 95.145: Report of a World Health Organization Consultation on Public Health Issues Relaced to Human and Animal Transmissible Spongiform Encophalopathies

By World Health Organization

Book Id: WPLBN0000047762
Format Type: PDF eBook:
File Size: 1.18 MB
Reproduction Date: 2005

Title:	World Health Organization : Year 1995 : Communicable Diseases and Emerging Infectious Diseases ; Vph, No. 95.145: Report of a World Health Organization Consultation on Public Health Issues Relaced to Human and Animal Transmissible Spongiform Encophalopathies
Author:	World Health Organization
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Health Organization, B. W. (n.d.). World Health Organization : Year 1995 : Communicable Diseases and Emerging Infectious Diseases ; Vph, No. 95.145. Retrieved from http://gutenberg.cc/

Description
Medical Reference Publication

Excerpt
A meeting on the traiismissible spongiform encephalopathies (TSE) was held in Geneva, Switzerland, from 17-19 May 1995. This group of diseases includes bovine spongiform encephalopathy (BSE) which was first described in the United Kingdom but which has occurred subsequently in several other countries.

Table of Contents
Table of Contents 1. INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .;.. . . . . . . . . . . . . . 5 2 . WORLDWIDE OCCURRENCE OF RECENTLY IDENTIFIED ANIMAL TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (TSEs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5. 2.1 BSE epidemiology and control . . . . . . . . . . . . . . . . . . . . . . .,.. . . . . . . . . . . . . . . . . . . . . . . .5 2.1.1 Country with a high incidence of BSE: UK . . . . . . . . . . . . . . . . . . .. ... . . . . . . . .5 2.1.2 Countries with lower incidence of BSE in native cattle . . . . . . . . . . . . . . . . . . . . . . . . .6 2.1.3 Countries and territories with BSE in imported cattle only . . . . . . . . . . . . . . . . . . . . . . 6 2.2 Other new animal TSEs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .6. 3 . CURRENT STATUS OF BSE RESEARCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 3.1 Experimental host range of BSE .................................................. 6 3.2 Tissue distribution of agent in confirmed cases of BSE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 3.3 Tissue distribution of agent in cattle during the incubation period . . . . . . . . . . . . . . . . . . . . . . . 7 3.4 Vertical and horizontal transmission studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 3.5 Strain characteristics of TSE agents in mice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8 3.6 BSE and scrapie agent deGontamination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8 4 . CREUTZFELDT-JAKOB DISEASE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9 4.1 Incidence of Creutzfeldt-Jakob disease . . . . . . . . . . . . . . . . . . . . .: . ..................... 9 4.2 Risk factors for Creutzfeldt-Jakob disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 4.2.1 %amgenicc ases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 4.2.2 Occupation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1 0. 4.2.3 Diet . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 4.2.4 Molecular Biology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1.0. 4.3 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1